Ewing Sarcoma
📧 Sign up to get email alerts when something new happens for Ewing Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy [NA]
Completed clinical trial evaluating the effects of preoperative physical therapy in patients with lower extremity bone sarcomas; results are…
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors [Phase 2]
Phase 2 trial evaluating a conditioning regimen of busulfan, melphalan, and thiotepa followed by donor stem cell transplant in patients with…
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides [Phase 1]
A Phase 1 clinical trial of Racotumomab in pediatric tumors expressing N-glycolylated gangliosides has completed enrollment and reported res…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Biomarkers in Tissue Samples From Patients With Ewing Sarcoma
This completed clinical trial update reports on biomarker analyses in tissue samples from patients with Ewing sarcoma.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood [Phase 2]
Phase 2 trial of imatinib mesylate in relapsed or refractory pediatric solid tumors has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors [Phase 2]
Phase 2 trial results for cixutumumab in relapsed or refractory solid tumors across multiple sarcomas and pediatric cancers.
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors [Phase 1]
This dose-escalation Phase 1 trial evaluated the safety and tolerability of combining Sorafenib with Irinotecan in pediatric patients with s…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Ixabepilone in Treating Young Patients With Refractory Solid Tumors [Phase 2]
Phase 2 trial update on ixabepilone in young patients with refractory solid tumors. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung [Phase 2]
Phase 2 study evaluating REOLYSIN (pelareorep) for bone and soft tissue sarcomas metastatic to the lung has been completed, assessing safety…
-
CLINICAL_TRIALS trial_result · 2014-09-02Clinical Trial Update: Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma [Phase 2]
Phase 2 trial results evaluating vincristine, topotecan, and cyclophosphamide with or without bevacizumab in young patients with refractory …
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma [Phase 3]
This document is an update on a Phase 3 clinical trial evaluating combination chemotherapy with or without peripheral stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor [Phase 1]
This is a completed Phase 1 clinical trial evaluating IMC-A12 (cixutumumab) in young patients with relapsed or refractory Ewing sarcoma/Peri…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) [Phase 2]
Phase 2 clinical trial evaluating sorafenib in patients with soft tissue sarcomas, including metastatic and recurrent subtypes; results were…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors [Phase 1, Phase 2]
Pfizer-sponsored Phase 1/2 study of CP-751,871 in patients with Ewing's sarcoma family of tumors completed and posted results in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors [NA]
This ClinicalTrials.gov entry reports the completion of a study comparing two combination chemotherapy regimens in younger patients with new…
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors [Phase 2]
Phase 2 clinical trial evaluating trabectedin in young patients with recurrent or refractory soft tissue sarcoma or Ewing's family tumors; s…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma [Phase 1]
Phase 1 clinical trial evaluating a cancer vaccine therapy in combination with Interleukin-2 for relapsed or refractory Ewing sarcoma or Neu…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors [Phase 1]
Phase 1 study of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with solid tumors, including Ewing sarcoma and other sarcomas…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma [Phase 2]
Phase 2 trial evaluating cytarabine in young patients with recurrent or refractory Ewing's sarcoma has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma [Phase 1, Phase 2]
An update on a National Cancer Institute–sponsored Phase 1/Phase 2 trial evaluating a therapy for Ewing sarcoma, rhabdomyosarcoma, and neuro…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma [Phase 2]
A completed Phase 2 trial evaluated irinotecan for newly diagnosed Ewing sarcoma.
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma [Phase 2]
This update reports on a Phase 2 clinical trial evaluating a combination of chemotherapy and biological therapy for high-risk Ewing sarcoma.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy and radiation therapy for Wilms tumor, Ewing's sarcoma, peripheral primitive ne…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment [Phase 2]
Phase 2 trial evaluating oxaliplatin in young patients with recurrent solid tumors that have not responded to prior treatment has completed.…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors [Phase 1]
Completed Phase 1 trial evaluating tanespimycin in pediatric patients with recurrent or refractory leukemia or solid tumors.